These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21142180)

  • 1. Novel flavaglines displaying improved cytotoxicity.
    Thuaud F; Ribeiro N; Gaiddon C; Cresteil T; Désaubry L
    J Med Chem; 2011 Jan; 54(1):411-5. PubMed ID: 21142180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic analogue of rocaglaol displays a potent and selective cytotoxicity in cancer cells: involvement of apoptosis inducing factor and caspase-12.
    Thuaud F; Bernard Y; Türkeri G; Dirr R; Aubert G; Cresteil T; Baguet A; Tomasetto C; Svitkin Y; Sonenberg N; Nebigil CG; Désaubry L
    J Med Chem; 2009 Aug; 52(16):5176-87. PubMed ID: 19655762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIF-1α inhibitors: synthesis and biological evaluation of novel moracin O and P analogues.
    Xia Y; Jin Y; Kaur N; Choi Y; Lee K
    Eur J Med Chem; 2011 Jun; 46(6):2386-96. PubMed ID: 21481991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel cyclopropapyrroloindole derivative (AT-3510) bearing methoxycarbonyl and trifluoromethyl groups.
    Fukuda Y; Furuta H; Kusama Y; Ebisu H; Oomori Y; Terashima S
    J Med Chem; 1999 Apr; 42(8):1448-58. PubMed ID: 10212131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity relationships of new benzodioxinic lactones as potential anticancer drugs.
    Romero M; Renard P; Caignard DH; Atassi G; Solans X; Constans P; Bailly C; Pujol MD
    J Med Chem; 2007 Jan; 50(2):294-307. PubMed ID: 17228871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents.
    Wei L; Shi Q; Bastow KF; Brossi A; Morris-Natschke SL; Nakagawa-Goto K; Wu TS; Pan SL; Teng CM; Lee KH
    J Med Chem; 2007 Jul; 50(15):3674-80. PubMed ID: 17585747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of polyenylpyrrole derivatives as anticancer agents acting through caspases-dependent apoptosis.
    Fang Z; Liao PC; Yang YL; Yang FL; Chen YL; Lam Y; Hua KF; Wu SH
    J Med Chem; 2010 Nov; 53(22):7967-78. PubMed ID: 20964408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of some novel benzofuran-2-yl(4,5-dihyro-3,5-substituted diphenylpyrazol-1-yl) methanones and studies on the antiproliferative effects and reversal of multidrug resistance of human MDR1-gene transfected mouse lymphoma cells in vitro.
    Parekh S; Bhavsar D; Savant M; Thakrar S; Bavishi A; Parmar M; Vala H; Radadiya A; Pandya N; Serly J; Molnár J; Shah A
    Eur J Med Chem; 2011 May; 46(5):1942-8. PubMed ID: 21396744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel class of in vivo active anticancer agents: achiral seco-amino- and seco-hydroxycyclopropylbenz[e]indolone (seco-CBI) analogues of the duocarmycins and CC-1065.
    Sato A; McNulty L; Cox K; Kim S; Scott A; Daniell K; Summerville K; Price C; Hudson S; Kiakos K; Hartley JA; Asao T; Lee M
    J Med Chem; 2005 Jun; 48(11):3903-18. PubMed ID: 15916443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavaglines as potent anticancer and cytoprotective agents.
    Ribeiro N; Thuaud F; Bernard Y; Gaiddon C; Cresteil T; Hild A; Hirsch EC; Michel PP; Nebigil CG; Désaubry L
    J Med Chem; 2012 Nov; 55(22):10064-73. PubMed ID: 23072299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antitumor effect in vitro and in vivo of substituted 1,3-dihydroindole-2-ones.
    Christensen MK; Erichsen KD; Trojel-Hansen C; Tjørnelund J; Nielsen SJ; Frydenvang K; Johansen TN; Nielsen B; Sehested M; Jensen PB; Ikaunieks M; Zaichenko A; Loza E; Kalvinsh I; Björkling F
    J Med Chem; 2010 Oct; 53(19):7140-5. PubMed ID: 20845961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and discovery of 5-hydroxyaurone derivatives as growth inhibitors against HUVEC and some cancer cell lines.
    Cheng H; Zhang L; Liu Y; Chen S; Cheng H; Lu X; Zheng Z; Zhou GC
    Eur J Med Chem; 2010 Dec; 45(12):5950-7. PubMed ID: 20974505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of 4/5-hydroxy-2,3-diaryl(substituted)-cyclopent-2-en-1-ones as cis-restricted analogues of combretastatin A-4 as novel anticancer agents.
    Gurjar MK; Wakharkar RD; Singh AT; Jaggi M; Borate HB; Shinde PD; Verma R; Rajendran P; Dutt S; Singh G; Sanna VK; Singh MK; Srivastava SK; Mahajan VA; Jadhav VH; Dutta K; Krishnan K; Chaudhary A; Agarwal SK; Mukherjee R; Burman AC
    J Med Chem; 2007 Apr; 50(8):1744-53. PubMed ID: 17373779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel allosteric mitogen-activated protein kinase kinase (MEK) 1,2 inhibitors possessing bidentate Ser212 interactions.
    Heald RA; Jackson P; Savy P; Jones M; Gancia E; Burton B; Newman R; Boggs J; Chan E; Chan J; Choo E; Merchant M; Rudewicz P; Ultsch M; Wiesmann C; Yue Q; Belvin M; Price S
    J Med Chem; 2012 May; 55(10):4594-604. PubMed ID: 22506516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
    Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
    J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationship studies of targeting ligands against breast cancer cells.
    Yao N; Xiao W; Meza L; Tseng H; Chuck M; Lam KS
    J Med Chem; 2009 Nov; 52(21):6744-51. PubMed ID: 19835381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and evaluation of novel thienopyrrolizinones as antitubulin agents.
    Lisowski V; Léonce S; Kraus-Berthier L; Sopková-de Oliveira Santos J; Pierré A; Atassi G; Caignard DH; Renard P; Rault S
    J Med Chem; 2004 Mar; 47(6):1448-64. PubMed ID: 14998333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-aroylindoles and 2-aroylbenzofurans with N-hydroxyacrylamide substructures as a novel series of rationally designed histone deacetylase inhibitors.
    Mahboobi S; Sellmer A; Höcher H; Garhammer C; Pongratz H; Maier T; Ciossek T; Beckers T
    J Med Chem; 2007 Sep; 50(18):4405-18. PubMed ID: 17691763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and preclinical evaluation of new 5,6- (or 6,7-) disubstituted-2-(fluorophenyl)quinolin-4-one derivatives as potent antitumor agents.
    Chou LC; Tsai MT; Hsu MH; Wang SH; Way TD; Huang CH; Lin HY; Qian K; Dong Y; Lee KH; Huang LJ; Kuo SC
    J Med Chem; 2010 Nov; 53(22):8047-58. PubMed ID: 20973552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of novel C14-hydroxyl substituted triptolide derivatives as potential selective antitumor agents.
    Li Z; Zhou ZL; Miao ZH; Lin LP; Feng HJ; Tong LJ; Ding J; Li YC
    J Med Chem; 2009 Aug; 52(16):5115-23. PubMed ID: 19637874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.